Clinicopathological characteristics of epidermal growth factor receptor gene mutation and mutantsite of lung adenocarcinomas patients in Hunan China

Lubiao Liang,Wolong Zhou,Yuanda Cheng,Yang Gao,Chunfang Zhang
DOI: https://doi.org/10.3969/j.issn.1672-4992.2015.21.011
2015-01-01
Journal of Modern Oncology
Abstract:Objective:To study the clinicopathological characteristics of epidermal growth factor receptor( EGFR) gene mutation and mutantsite of lung adenocarcinomas patients in Hunan China. Methods:All 134 tissue samples of lung adenocarcinomas were analyzed for epidermal growth factor receptor mutations in exons 18,19,20 and 21 using amplification refractory mutation system(ARMS). Collected clinical data and analyzed using SPSS 16. 0 software. Re-sults:EGFR mutations were detected in 68 patients among the 134 lung adenocarcinoma patients . The mutation rate was 50. 7%. The mutation rates in male and female were 40.7%(24/59),58.7%(44/75)respectively(P =0.039),smoKers and non -smoKers mutation rates were 30. 6%(15/49),62.4%(53/85)respectively(P=0. 000). The cases of mutation in exon 18,19,20,21 were 2(2. 9%),32(47. 1%),3(4. 4%)and 31(45. 6%)re-spectively. There was difference mutation in exon 19 and 21 between stages I-II and III-IV,and the mutation rate of exon 21 was higher than that of exon 19 in stages I-II(P=0. 048). Conclusion:EGFR mutation rate is higher in female,non-smoKers in lung adenocarcinoma from Hunan China and the most common EGFR mutations are deletions in exon 19 and 21. Meanwhile there is difference for mutation in exon 19 and 21 between I-II and III-IV TNM stage. Compared with mutation in exon 19,the mutation of exon 21 was higher in stages I-II than stages III-IV.
What problem does this paper attempt to address?